| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.5M | +1.8% |
| Cost of Revenue | $4.1M | +75.9% |
| Gross Profit | $15.4M | -8.4% |
| R&D Expense | $2.8M | +40.4% |
| SG&A Expense | $8.5M | +4.9% |
| Pre-tax Income | $889K | -74.0% |
| Income Tax | $219K | -76.9% |
| Net Income | $670K | -83.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.8M | +224.8% |
| Accounts Receivable | $1.6M | -26.3% |
| Current Assets | $10.8M | +57.2% |
| Total Assets | $15.8M | +37.1% |
| Current Liabilities | $2.1M | -55.4% |
| Total Liabilities | $2.6M | -52.0% |
| Stockholders' Equity | $13.2M | +116.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.2M | +42.3% |
| Investing Cash Flow | -$837K | +57.0% |
| Financing Cash Flow | $4.1M | +204.6% |